Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 2, 2005, Pages 2788-2803

  Gober, Michael D ^a,b   Wales, Samantha Q ^a   Aurelian, Laure ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Apoptosis; Cell death; H11; Heat shock protein; Hsp; HSV 2; ICP10; Review; Virus

Indexed keywords

CELL PROTEIN; CHAPERONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; PROTEIN; PROTEIN BCL 2; PROTEIN KINASE; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; LATENT PERIOD; MACHINE; MORALITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TARGETING; STRUCTURAL HOMOLOGY; UPREGULATION; VIRUS; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 21344465226     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1736     Document Type: Article

References (120)

1. Gober MD, Smith CC, Ueda K, Toretsky JA, and Aurelian L. Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells. J Biol Chem 278, 37600-37609 (2003)
2. Smith CC, Yu YX, Kulka M, Aurelian L. A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells. J Biol Chem 275, 25690-25699 (2000)
3. Aurelian L, Smith CC, Winchurch R, Kulka M, Gyotoku T, Zaccaro L, Chrest FJ, and Burnett JW. A novel gene expressed in human keratinocytes with long-term in vitro growth potential is required for cell growth. J Invest Dermatol 116, 286-295 (2001)
4. Cory S, Huang DC and Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22, 8590-8607 (2003)
5. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2, 222-228 (2001)
6. Scheid MP, Schubert KM and Duronio V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 274, 31108-31113 (1999)
7. del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-9 (1997)
8. Perkins D, Pereira EF and Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J Virol 77, 1292-1305 (2003)
9. Franke TF, Hornik CP, Segev L, Shostak GA, and Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983-8998 (2003)
10. Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64, 7183-7190 (2004)
11. Verhagen AM and Vaux DL. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7, 163-166 (2002)
12. Mosser DD and Morimoto RI. Molecular chaperones and the stress of oncogenesis. Oncogene 23, 2907-2918 (2004)
13. Samali A and Orrenius S. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 3, 228-236 (1998)
14. Soti C, Sreedhar AS and Csermely P. Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch. Aging Cell 2, 39-45 (2003)
15. Feng H, Zeng Y, Graner MW and Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100, 4108-4115 (2002)
16. Liossis SN, Ding XZ, Kiang JG and Tsokos GC. Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells. J Immunol 158, 5668-5675 (1997)
17. Chen G, Cao P and Goeddel DV. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. Mol Cell 9, 401-410 (2002)
18. Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, and Kohn EC. CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem 278, 28490-28500 (2003)
19. Luders J, Demand J, and Hohfeld J. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem 275, 4613-4617 (2000)
20. McClellan AJ, and Frydman J. Molecular chaperones and the art of recognizing a lost cause. Nat Cell Biol ;3, E51-53 (2001)
21. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N, Mak T, Jaattela M, Penninger JM, Garrido C, and Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 3, 839-843 (2001)
22. Gullo CA and Teoh G. Heat shock proteins: to present or not, that is the question. Immunol Lett 94, 1-10 (2004)
23. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2, 185-194 (2002)
24. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, and Calderwood SK. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6, 435-442 (2000)
25. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, and Lehner T. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol 169, 2422-2429 (2002)
26. Beere HM and Green DR. Stress management - heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol 11, 6-10 (2001)
27. Song J, Takeda M and Morimoto RI. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol 3, 276-282 (2001)
28. Stuart JK, Myszka DG, Joss L, Mitchell RS, McDonald SM, Xie Z, Takayama S, Reed JC and Ely KR. Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones. J Biol Chem 273, 22506-22514 (1998)
29. Schett G, Steiner CW, Groger M, Winkler S, Graninger W, Smolen J, Xu Q and Steiner G. Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70. FASEB J 13, 833-842 (1999)
30. Ahn JH, Ko YG, Park WY, Kang YS, Chung HY and Seo JS. Suppression of ceramide-mediated apoptosis by HSP70. Mol Cells 9, 200-206 (1999)
31. Meriin AB, Yaglom JA, Gabai VL, Zon L, Ganiatsas S, Mosser DD, Zon L, Sherman MY. Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol Cell Biol 19, 2547-2555 (1999)
32. Klein SD and Brune B. Heat-shock protein 70 attenuates nitric oxide-induced apoptosis in RAW macrophages by preventing cytochrome c release. Biochem J 362, 635-641 (2002)
33. Mosser DD, Caron AW, Bourget L, Denis-Larose C and Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17, 5317-5327 (1997)
34. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM and Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2, 469-475 (2000)
35. Park HS, Cho SG, Kim CK, Hwang HS, Noh KT, Kim MS, Huh SH, Kim MJ, Ryoo K, Kim EK, Kang WJ, Lee JS, Seo JS, Ko YG, Kim S, and Choi EJ. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol 22, 7721-7730 (2002)
36. Park HS, Lee JS, Huh SH, Seo JS and Choi EJ. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J 20, 446-456 (2001)
37. Yaglom JA, Gabai VL, Meriin AB, Mosser DD and Sherman MY. The function of HSP72 in suppression of c-Jun N-terminal kinase activation can be dissociated from its role in prevention of protein damage. J Biol Chem 274, 20223-20228 (1999)
38. Jaattela M, Wissing D, Kokholm K, Kallunki T, and Egeblad M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17, 6124-6134 (1998)
39. Pratt WB and Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med 228, 111-133 (2003)
40. Schulte TW, Blagosklonny MV, Ingui C and Neckers L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J Biol Chem 270, 24585-24588 (1995)
41. Sato S, Fujita N, and Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A 97, 10832-10837 (2000)
42. Pandey P, Saleh A, Nakazawa A, Kumar S, Srimvasula SM, Kumar V, Weichselbaum R, Nalin C, Alnemri ES, Kufe D and Kharbanda S. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19, 4310-4322 (2000)
43. Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L and Liu ZG. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 275, 10519-10526 (2000)
44. Galea-Lauri J, Richardson AJ, Latchman DS and Katz DR. Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology. J Immunol 157, 4109-4118 (1996)
45. Garrido C, Gurbuxani S, Ravagnan L and Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286, 433-442 (2001)
46. Mehlen P, Schulze-Osthoff K and Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271, 16510-16514 (1996)
47. Samali A and Cotter TG. Heat shock proteins increase resistance to apoptosis. Exp Cell Res 223, 163-170 (1996)
48. Concannon CG, Orrenius S and Samali A. Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr 9, 195-201 (2001)
49. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13, 2061-2070 (1999)
50. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E and Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2, 645-652 (2000)
51. Paul C, Manero F, Gonin S, Kretz-Remy C, Virot S and Arrigo AP. Hsp27 as a negative regulator of cytochrome C release. Mol Cell Biol 22, 816-834 (2002)
52. Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N, Catley L, Tai YT, Hayashi T, Shringarpure R, Burger R, Munshi N, Ohtake Y, Saxena S and Anderson KC. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. Blood 102, 3379-3386 (2003)
53. Charette SJ, Lavoie JN, Lambert H, and Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol 20, 7602-7612 (2000)
54. Konishi H, Matsuzaki H, Tanaka M, Takemura Y, Kuroda S, Ono Y, Kikkawa U. Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27. FEBS Lett 410, 493-498 (1997)
55. Preville X, Salvemini F, Giraud S, Chaufour S, Paul C, Stepien G, Ursini MV and Arrigo AP. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res 247, 61-78 (1999)
56. Geum D, Son GH and Kim K. Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J Biol Chem 277, 19913-19921 (2002)
57. Parcellier A, Schmitt E, Gurbuxani S, Seigneurin-Berny D, Pance A, Chantome A, Plenchette S, Khochbin S, Solary E, and Garrido C. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23, 5790-5802 (2003)
58. Chowdary TK, Raman B, Ramakrishna T, and Rao CM. Mammalian Hsp22 is a heat-inducible small heat-shock protein with chaperone-like activity. Biochem J 381, 379-387 (2004).
59. Depre C, Hase M, Gaussin V, Zajac A, Wang L, Hittinger L, Ghaleh B, Yu X, Kudej RK, Wagner T, Sadoshima J, and Vatner SF. H11 kinase is a novel mediator of myocardial hypertrophy in vivo. Circ Res 91, 1007-1014 (2002)
60. Hase M, Depre C, Vatner SF, and Sadoshima J. H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes. Biochem J [Epub ahead of print] (2005)
61. la Cour T, Gupta R, Rapacki K, Skriver K, Poulsen FM, and Brunak S. NESbase version 1.0: a database of nuclear export signals. Nucleic Acids Res 31, 393-396 (2003)
62. Tawil NJ, Houde M, Blacher R, Esch F, Reichardt LF, Turner DC and Carbonetto S. Alpha 1 beta 1 integrin heterodimer functions as a dual laminin/collagen receptor in neural cells. Biochemistry 29, 6540-6544 (1990)
63. Liang YL, Fu Y, Chen SG, Cai XM, Su JM, Jin JW, Ma DZ, Li ZX, Zhang W, and Zha X. Integrin beta1 subunit overexpressed in the SMMC-7721 cells regulates the promoter activity of p21 (CIP1) and enhances its transcription. FEBS Lett 558, 107-113 (2004)
64. Henriet P, Zhong ZD, Brooks PC, Weinberg KI and DeClerck YA. Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci USA 97, 10026-10031 (2000).
65. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, and Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001)
66. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, and Radinsky R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15, 3032-3040 (1995)
67. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, and Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9, 1791-1798 (1994)
68. Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ, and Kang HS. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 81, 573-579 (2001)
69. Lo PK, Huang SZ, Chen HC and Wang FF. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling. Cancer Res 64, 8736-8745 (2004)
70. Liu J, Li C, Ahlborn TE, Spence MJ, Meng L and Boxer LM. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. Cell Growth Differ 10, 677-683 (1999)
71. Ferreira A and Kosik KS. Accelerated neuronal differentiation induced by p53 suppression. J Cell Sci 109, 1509-1516 (1996)
72. Soloveva V and Linzer DI. Differentiation of placental trophoblast giant cells requires downregulation of p53 and Rb. Placenta 25, 29-36 (2004)
73. Zalcenstein A, Stambolsky P, Weisz L, Muller M, Wallach D, Goncharov TM, Krammer PH, Rotter V and Oren M. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 22, 5667-5676 (2003)
74. Everett H and McFadden G. Poxviruses and apoptosis: a time to die. Curr Opin Microbiol 5, 395-402 (2002)
75. Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P and Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 190, 1025-1032 (1999)
76. White E. Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 20, 7836-7846 (2001)
77. Perez D and White E. TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol Cell 6, 53-63 (2000)
78. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS and Hardwick JM. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94, 690-694 (1997)
79. Nava VE, Cheng EH, Veliuona M, Zou S, Clem RJ, Mayer ML and Hardwick JM. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 71, 4118-4122 (1997)
80. Cuconati A and White E. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 16, 2465-2478 (2002).
81. Cleary ML, Smith SD and Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19-28 (1986)
82. Huang Q, Petros AM, Virgin HW, Fesik SW and Olejniczak ET. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A 99, 3428-3433 (2002)
83. Huang Q, Petros AM, Virgin HW, Fesik SW and Olejniczak ET. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol 332, 1123-1130 (2003)
84. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968 (1997)
85. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ and Makela TP. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2, 819-825 (2000)
86. Bellows DS, Chau BN, Lee P, Lazebnik Y, Burns WH, and Hardwick JM. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74, 5024-5031 (2000)
87. Clem RJ and Miller LK. Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 14, 5212-5222 (1994)
88. Menzo S, Clementi M, Alfani E, Bagnarelli P, lacovacci S, Manzin A, Dandri M, Natoli G, Levrero M and Carloni G. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. Virology 196, 878-882 (1993)
89. Miller WE, Earp HS and Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 69, 4390-4398 (1995)
90. Cohen BD, Goldstein DJ, Rutledge L, Vass WC, Lowy DR, Schlegel R, and Schiller JT. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J Virol 67, 5303-5311 (1993)
91. Miller WE and Raab-Traub N. The EGFR as a target for viral oncoproteins. Trends Microbiol 7, 453-458 (1999)
92. Rodems SM and Spector DH. Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol 72, 9173-9180 (1998)
93. Smith CC, Peng T, Kulka M, and Aurelian L. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J Virol 72, 9131-9141 (1998)
94. Dawson CW, Tramountanis G, Eliopoulos AG and Young LS. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278, 3694-3704 (2003)
95. Swart R, Ruf IK, Sample J and Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74, 10838-10845 (2000)
96. Darr CD, Mauser A and Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol 75, 6135-6142 (2001)
97. Lee YI, Kang-Park S, Do SI and Lee YI. The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276, 16969-16977 (2001)
98. Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L and Huang ES. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol 71, 5051-5059 (1997)
99. Milani D, Mazzoni M, Borgatti P, Zauli G, Cantley L and Capitani, S. Extracellular human immunodeficiency virus type-1 (HIV-1) Tat protein activates PI 3-Kinase in PC12 neuronal cells. J Biol Chem 271,22961-22964 (1996)
100. Geleziunas R, Xu W, Takeda K, Ichijo H and Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410, 834-838 (2001)
101. Agranovsky AA, Boyko VP, Karasev AV, Koonin EV and Dolja VV. Putative 65 kDa protein of beet yellows closterovirus is a homologue of HSP70 heat shock proteins. J Mol Biol 217, 603-610 (1991)
102. Karasev AV, Kashina AS, Gelfand VI and Dolja VV. HSP70-related 65 kDa protein of beet yellows closterovirus is a microtubule-binding protein. FEBS Lett 304, 12-14 (1992)
103. Agranovsky AA, Folimonova SY, Folimonov AS, Denisenko ON and Zinovkin RA. The beet yellows closterovirus p65 homologue of HSP70 chaperones has ATPase activity associated with its conserved N-terminal domain but does not interact with unfolded protein chains. J Gen Virol 78, 535-542 (1997)
104. Yamauchi Y, Wada K, Goshima F, Daikoku T, Ohtsuka K and Nishiyama Y. Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions. J Cell Sci 115, 2517-2527 (2002)
105. Yamauchi Y, Daikoku T, Goshima F and Nishiyama Y. Herpes simplex virus UL14 protein blocks apoptosis. Microbiol Immunol 47, 685-689 (2003)
106. Aurelian L. Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase. Front Biosci 3, d237-d249 (1998)
107. Chabaud S, Lambert H, Sasseville AM, Lavoie H, Guilbault C, Massie B, Landry J, and Langelier Y. The R1 subunit of herpes simplex virus ribonucleotide reductase has chaperone-like activity similar to Hsp27. FEBS Lett 545, 213-218 (2003)
108. Williams GT, McClanahan TK and Morimoto RI. E1a transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex. Mol Cell Biol 9, 2574-2587 (1989)
109. Kobayashi K, Ohgitani E, Tanaka Y, Kita M and Imanishi J. Herpes simplex virus-induced expression of 70 kDa heat shock protein (HSP70) requires early protein synthesis but not viral DNA replication. Microbiol Immunol 38, 321-325 (1994)
110. Sainis I, Angelidis C, Pagoulatos G, and Lazaridis I. The hsc70 gene which is slightly induced by heat is the main virus inducible member of the hsp70 gene family. FEBS Lett 355, 282-286 (1994)
111. Wang HG, Takayama S, Rapp UR, and Reed JC Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci U S A 93, 7063-7068 (1996)
112. Luders J, Demand J, Papp O, and Hohfeld J. Distinct isoforms of the cofactor BAG-1 differentially affect Hsc70 chaperone function. J Biol Chem 275, 14817-14823 (2000)
113. Wymer JP, Chung TD, Chang Y-N, Hayward GS, and Aurelian L. Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2. J Virol 63, 2773-2784 (1989)
114. Zhu J, and Aurelian L. AP-1 cis-response elements are involved in basal expression and vmx110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). Virology 231, 301-312 (1997)
115. Valyi-Nagy T, Deshmane S, Dillner A, and Fraser NW. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J Virol 65, 4142-4152 (1991)
116. Maroni P, Bendinelli P, Tiberio L, Rovetta F, Piccoletti R, and Schiaffonati L. In vivo heat-shock response in the brain: signalling pathway and transcription factor activation. Mol Brain Res 119, 90-99 (2003)
117. Aurelian L, Kokuba H, and Smith CC. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10). Vaccine 17, 1951-1963 (1999)
118. Wachsman M, Kulka M, Smith CC, and Aurelian L. A growth and latency compromised herpes simplex virus type 2 mutant (ICP10-delta-PK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine 19, 1879-1890 (2001)
119. Aurelian L and Smith CC. Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1). Antisense Nucleic Acid Drug Dev 10, 77-85 (2000)
120. Gyotoku T, Ono F, and Aurelian L. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.Vaccine 20,2796-2807 (2002)